Insulin-coated gold nanoparticles as a new concept for personalized and adjustable glucose regulation

Malka Shilo, Peter Berenstein, Tamar Dreifuss, Yuval Nash, Guy Goldsmith, Gila Kazimirsky, Menachem Motiei, Dan Frenkel, Chaya Brodie, Rachela Popovtzer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Diabetes mellitus is a chronic metabolic disease, characterized by high blood glucose levels, affecting millions of people around the world. Currently, the main treatment for diabetes requires multiple daily injections of insulin and self-monitoring of blood glucose levels, which markedly affect patients' quality of life. In this study we present a novel strategy for controlled and prolonged glucose regulation, based on the administration of insulin-coated gold nanoparticles (INS-GNPs). We show that both intravenous and subcutaneous injection of INS-GNPs into a mouse model of type 1 diabetes decreases blood glucose levels for periods over 3 times longer than free insulin. We further showed that conjugation of insulin to GNPs prevented its rapid degradation by the insulin-degrading-enzyme, and thus allows controlled and adjustable bio-activity. Moreover, we assessed different sizes and concentrations of INS-GNPs, and found that both parameters have a critical effect in vivo, enabling specific adjustment of blood glucose levels. These findings have the potential to improve patient compliance in diabetes mellitus.

Original languageEnglish
Pages (from-to)20489-20496
Number of pages8
Issue number48
StatePublished - 28 Dec 2015


Dive into the research topics of 'Insulin-coated gold nanoparticles as a new concept for personalized and adjustable glucose regulation'. Together they form a unique fingerprint.

Cite this